Amanda Thompson leads all quality control activities for our clinical manufacture of cellular therapies. During her time at Aspire, Ms. Thompson has developed and optimized protocols for Flow Cytometry, Cellular Therapy processing and cryopreservation. She has also led the QC lab expansion efforts, designed and executed validation studies for Aspire’s cellular therapies for various QC testing services.
Prior to joining Aspire, Ms. Thompson’s experience spanned various areas such as pharmaceuticals, process development, water science and clinical manufacturing.Ms. Thompson received her BSc and MSc in Chemistry from Northeastern University.
Ms. Thompson received her BSc and MSc in Chemistry from Northeastern University..